ADAR1 Capital Management »

Jd shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Jd (JD) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Jd

Tip: Access up to 7 years of quarterly data

All positions including Jd held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jd by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $350k 10k 34.98
2024-03-31 $110k 4.0k 27.39

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Keros Therapeutics (KROS)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Immunovant (IMVT)
89bio (ETNB)
Zai Lab Adr (ZLAB)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Uniqure Nv SHS (QURE)
Prothena Corp SHS (PRTA)
Bridgebio Pharma (BBIO)
Arbutus Biopharma (ABUS)

View all positions for ADAR1 Capital Management

Top funds holding Jd

Susquehanna International
Dodge & Cox
Citadel Advisors
Lombard Odier Asset Management
Jane Street
Invesco
Newlands Management Operations
Fil
Susquehanna Advisors Group
UBS Group
Goldman Sachs Group
Walleye Trading
Appaloosa
Discerene Group
CoreView Capital Management

View all funds holding Jd